Ensoma
Boston, US · 7 known investors
Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment. Its technology aims to selectively and durably modify cells of the hematopoietic system for patients.
BiotechHealthtechMedical Devices
Investors · 7
Frequently asked questions
- What does Ensoma do?
- Ensoma is a genomic medicine company developing a platform for in vivo engineering of hematopoietic stem cells (HSCs), combining an off-the-shelf delivery system with a gene engineering toolkit intended to treat diseases with a one-time treatment. Its technology aims to selectively and durably modify cells of the hematopoietic system for patients.
- Who are Ensoma's investors?
- Ensoma's investors include 5AM Ventures, Aju IB Invesment Corporation, Catalio Capital Management, LP, Delos Capital, F-Prime Capital Partners, Solasta Ventures, Bioluminescence Ventures.
- Where is Ensoma headquartered?
- Ensoma is headquartered in Boston, US.